stocksfeed.ai
← Back to news feed

IONS overview

IONS
Ionis Pharmaceuticals, Inc.
27.39
USD
-1.89 (-6.45%)since Nov 16, 2026

News about IONS

1 story shown

BIIBIONSproduct launch

Biogen announced two-year data from the Phase 2 CELIA study showing that its investigational therapy diranersen slowed clinical decline in early Alzheimer's disease.

Benzinga
View original